Healthcare

Trust DAK To Help Your Business Thrive

For over four decades, DAK has been a valuable business resource in the healthcare sector, forging deep and meaningful connections both domestically and internationally. We’re more than just a partner; we’re an extension of your vision. We have dedicated ourselves to the aspirations of middle-market healthcare business owners, helping them to realize the maximum return on their life’s work. Whether you’re seeking to understand the inherent worth of your enterprise, aiming for strategic growth, or searching for the perfect sale or merger opportunity, DAK will be by your side, guiding and supporting you every step of the way.

  • Home-Based Care
  • Behavioral Healthcare
  • Healthcare IT
  • Laboratories & Testing Facilities
  • Pharmaceuticals
  • Medical Equipment & Supply Manufacturers and Distributors

Sign up for Thought Leadership or Contact an Expert

Click to view some of DAK’s Successful Healthcare Transactions:

<-- Scroll left / right to view more -->
Scroll to Top

Focus Forward Skilled Care has been acquired by Sonas Home Health Care

Focus Forward Skilled Care LLC is a leading, multi-site provider of skilled pediatric home health care services based in Orlando, Florida. Originally founded in the mid 2010’s, they are renowned for their high standard of care to at-risk, high acuity pediatric patient populations. Focus Forward was acquired by Sonas Home Healthcare, a leading provider of pediatric and skilled health care services.

DAK served as the exclusive investment banker and financial advisor to FFSC initiating and managing the entire transaction process. DAK conducted a highly strategic buyer search to identify a set of exceptional acquirers of which Sonas Home Health Care emerged as the superior partner to bring these two leading companies together.

The owners of Focus Forward Skilled Care have created a superior company built with a focus on a high standard of care and strong patient outcomes. With this transaction, they have been able to extend their services to an even broader patient community with a strategic partner which will accelerate the company’s growth.

BioMedtrix, LLC has been acquired by Kyon

BioMedtrix Kyon

BioMedtrix is a 30+ year leading Northeast-based designer and developer of state-of-the-art, innovative veterinary orthopedics for canine and feline implant products serving 650+ university and specialty clinic customers.

DAK led a competitive, sell-side process for BioMedtrix after considering a pre-emptive offer. DAK positioned BioMedtrix to highlight their key value drivers: significant top- and bottom-line growth, exceptional margins and potential for major expansion. These key characteristics were particularly attractive to Fidelio Capital and its portfolio company, Kyon, the BioMedtrix of Europe.

The acquisition gives the majority owner of BioMedtrix liquidity and the ability to continue operating the business he loves. The combination allows Fidelio Capital and Kyon to dominate the market category in both the United States in Europe and to expand product lines and market share.

Harrison Research Lab has been acquired by SGS North America, Inc.

HRL SGS

DAK was engaged by Harrison Research Labs a leading independent research organization to the cosmetic, beauty and over-the-counter pharmaceutical industries, providing clinical testing of topically applied skin, eye and hair products on human subjects.

Building on HRL’s leading industry reputation, prominent international clientele base and highly trained staff, DAK led a worldwide search and sold the company to a U.S. subsidiary of SGS, the world’s leading testing and certification company.

By acquiring the industry leader, the transaction provided SGS with the ability to expand its growing presence in the clinical testing sector for cosmetic and personal care products in the U.S.

Marypaul Laboratories has been acquired by EMSL Analytical, Inc.

Marypaul Labs is a leading, full-service microbiology contract testing laboratory serving a variety of industries including pharmaceutical, cosmetic and personal care, food ingredients and water.

DAK led a competitive, sell-side process for Marypaul highlighting its outstanding reputation in the industry for quality service, with excellent customer relationships many spanning over 20-30 years. Marypaul also had FDA and DEA registrations, multiple accreditations and certifications, and was an approved lab for several major consumer product companies.

Marypaul was acquired by EMSL Analytical, Inc, the nation’s leading environmental testing firm. The acquisition marked an expansion strategy for EMSL Analytical, Inc., who planned to offer Marypaul’s services to its current customers, served in 40 locations throughout the US and Canada. In addition, MPL’s clients will now have access to EMSL’s vast array of services. EMSL would maintain the Marypaul staff and facility in Sparta, NJ and planned on a seamless transition.

Air Techniques, Inc. has acquired a minority interest in Micrylium and exclusive distribution rights for Monarch

AirTech Micrylium

Air Techniques is a leading manufacturer of imaging equipment and supplies for the dental practitioner market. DAK was retained by Air Techniques to identify and investigate its options for strategic growth including the idea of a joint venture or purchase. DAK worked with the management of Air Techniques to identify its primary objectives for potential acquisition as well as the ideal target profile. DAK identified Micrylium as a potential target and led the negotiations which gave Air Techniques the exclusive distribution rights for its Monarch infection control products in the country.

Prior to approaching potential targets, DAK identified several key growth objectives for Air Techniques including broadening its product portfolio, mitigating business fluctuations, diversifying its customer base and growing its internal sales team in order to become less dependent on third-party distributors. Air Techniques was particularly attracted to the Monarch infection control line since these products were designed exclusively for use on surfaces, instruments and equipment in a dental office setting. This investment allowed Air Techniques to meet its objective of broadening its suite of products.

Applied Nutrition Corporation has been acquired by Nutricia, a unit of Danone (OTCQX: DANOY)

Applied Nutricia

Applied Nutrition Corporation, a 20-year-old manufacturer of highly specialized medical food formulations to treat patients with phenylketonuria (PKU) and other inherited metabolic disorders, has been acquired by Nutricia North America, the U.S. unit of the medical nutrition business of French conglomerate Danone International (OTCQX: DANOY).

DAK served as the exclusive investment banker and financial advisor to Applied Nutrition, managing the divestiture process. Applied Nutrition had received an indication of interest from Danone prior to engaging DAK. By emphasizing the highly complementary strengths of the two organizations and the synergies that could result from a transaction, DAK was able to raise the initial offer significantly.

Given Applied Nutrition’s long-standing history of supporting the affected metabolic community, cultural compatibility and sharing of core values was a key component of the transaction. The owners of Applied Nutrition were confident that a combination of Nutricia and Applied Nutrition will continue to focus on enhancing the lives of those that require advanced medical nutrition products for specialized care and were extremely pleased with the outcome.

Amesil, Inc. has been acquired by W. L. Gore & Associates

Amesil Gore

Amesil, Inc., a manufacturer of non-reactive fluid transfer containment and sampling systems for the bio-pharmaceutical, bio-technology and pharmaceutical industries, has been acquired by W. L. Gore & Associates, an American multinational manufacturing company specializing in products derived from fluoropolymers.

DAK acted as financial advisor to Amesil and its parent company, Ames Rubber Corp., in its sale to W.L. Gore & Associates. The DAK group led a targeted process and highlighted the Amesil’s comprehensive line of products and a loyal customer base.

Through the acquisition, Gore enhanced its product leadership in the biopharmaceutical category and continues to manufacture and sell Amesil products with the same high standards and outstanding commitment to service.

Water-Jel Technologies, Inc. has been acquired by The Riverside Company

WaterJel Riverside

Water-Jel Technologies, Inc., a manufacturer of medical devices and burn care products for use by emergency first responder, military, industrial and consumer markets, has been acquired by The Riverside Company, a New York-based private equity firm managing funds totaling $4 billion.

Advised Water-Jel Technologies on its sale to The Riverside Company, a New York-based private equity firm managing funds totaling $4 billion.

Interactive Systems & Management Corporation has merged with The Opus Companies

ISM OPUS

Interactive Systems & Management Corporation, a provider of computer services to small businesses, particularly the pharmacy industry, since 1976 using its IntelRx™ family of systems and services, has merged with The Opus Companies, a provider of computer systems and services for chain and independent pharmacies since 1982.

DAK acted as financial advisor to ISM in the merger with The Opus Companies.

This transaction combines strong and well-regarded, service-oriented companies with highly strategic product lines. Together, they are an even more dominant force in the industry and customers will greatly benefit from the increased resources to step up the pace of software development and the unique product lines that complement each other in many ways.

Glenwood, LLC has been acquired by Purepac Pharmaceutical Company

Purepac

Glenwood, LLC, a provider of pharmaceutical contract manufacturing services and distributor of proprietary pharmaceuticals, medical bandages, personal care products and dental devices, has been acquired by Purepac Pharmaceutical Company, a division of Faulding Holdings, Inc.

DAK acted as financial advisor to Glenwood in the sale of its 112,000 square foot FDA Approved manufacturing facility.

This transaction allowed for Purepac to acquire additional manufacturing operations and facilities to increase their volume and profitability.

VCI – Emergency Vehicle Specialists recapitalized by Tightrope Capital & NewSpring Capital

VCI is the preeminent full lifecycle sales and service provider of emergency ambulance solutions to first aid squads, EMS organizations, fire departments, hospital organizations, municipalities, and private medical transport companies in the Mid-Atlantic Region. VCI was recapitalized by private equity firms Tightrope Capital Partners and NewSpring Capital.

DAK led a competitive, sell-side process for VCI, generating multiple offers from a wide range of strategic buyers and financial sponsors. By positioning the combination of VCI’s market leadership position, comprehensive services offering, strong manufacturer relationships, and robust backlog, DAK achieved an outstanding outcome for the company’s shareholders.

The acquisition provides the shareholders of VCI an opportunity to accelerate its growth strategy by expanding its core ambulance business, building out the value-added segments of conversions and remounts, implementing operational improvements, and pursuing acquisitions with the help of its new partners. Tightrope and NewSpring have an opportunity to leverage VCI’s strong management team and operating platform to build a multi-regional player in emergency ambulance solutions.

Skip to content